TIRZEPATIDE (THE SAME ACTIVE INGREDIENT IN MOUNJARO®AND ZEPBOUND®)

Monthly subscription starting at $550 per month + shipping.

Included in the price.

  • Initial consultation
  • One month supply of Tirzepatide shipped to your home
  • Support via patient portal for questions or concerns

Tirzepatide FAQs

Tirzepatide is a medication originally developed to treat type 2 diabetes. It is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. It works by mimicking these hormones, which helps regulate blood sugar levels, reduce appetite, slow gastric emptying, and increase feelings of fullness, thereby aiding in weight loss.

Common side effects of Tirzepatide include nausea, vomiting, diarrhea, constipation, and abdominal pain. These gastrointestinal side effects are typically mild to moderate and tend to decrease over time as the body adjusts to the medication.

Tirzepatide is administered as a once-weekly subcutaneous injection. The dosage is gradually increased over several weeks to help minimize side effects and allow the body to adjust to the medication. The specific dosing schedule and adjustments are determined by a healthcare provider.

Tirzepatide for weight loss may be prescribed to adults with a body mass index (BMI) of 30 or greater (obesity) or a BMI of 27 or greater (overweight) with at least one weight-related condition such as hypertension, type 2 diabetes, or high cholesterol. Eligibility is determined by a healthcare provider based on a comprehensive medical evaluation.

Clinical trials have shown that patients taking Tirzepatide can experience significant weight loss. On average, patients may lose about 15-20% of their body weight over a 72-week period. The degree of weight loss can vary depending on adherence to the medication, lifestyle changes, and individual health factors.

While Tirzepatide has shown promising results in clinical trials, long-term safety data is still being gathered. Potential risks include pancreatitis, gallbladder disease, and gastrointestinal issues. Regular monitoring by a healthcare provider is essential to manage any potential risks and to ensure the medication remains appropriate for the patient's health needs. Additionally, because it is a newer medication, ongoing studies will provide more information on its long-term safety and efficacy.